Leaflet AERRANE 100% volatile liquid for inhalations


Indicated for: general anesthesia; procedural sedation

Route of administration: inhalation

Substance: isoflurane (general anesthetic)

ATC: N01AB06 (Nervous system | Anesthetics, general | Halogenated hydrocarbons)

Isoflurane is an inhalation anesthetic agent used for the induction and maintenance of general anesthesia. It works by depressing the central nervous system, inducing a state of unconsciousness and muscle relaxation.

The medication is administered via inhalation using a specialized vaporizer, under the supervision of an anesthesiologist. It is important to monitor the patient's vital signs during anesthesia.

Side effects may include hypotension, nausea, vomiting, or postoperative shivering. In rare cases, malignant hyperthermia or severe allergic reactions may occur.

Isoflurane is not recommended for patients with hypersensitivity to this medication or a history of malignant hyperthermia.

General data about AERRANE 100%

  • Substance: isoflurane
  • Date of last drug list: 01-03-2022
  • Commercial code: W43418002
  • Concentration: 100%
  • Pharmaceutical form: volatile liquid for inhalations
  • Packing volume: 250ml
  • Product type: generic
  • Prescription restrictions: S - Medicines prescription reserved for use in certain specialized fields.

Marketing authorisation

  • Manufacturer: BAXTER SA - BELGIA
  • Holder: BAXTER SA - BELGIA
  • Number: 13267/2020/02
  • Shelf life: 5 years

Pharmaceutical forms available for isoflurane

Concentrations available for isoflurane

  • 100%
  • 99.9%